SEA 0.00% 3.2¢ seadragon limited

Ann: GENERAL: SEA: SEA raises $3m from CVT; confirms exit from Omega-2 market

  1. lightbulb Created with Sketch. 2
    • Release Date: 27/05/16 11:50
    • Summary: GENERAL: SEA: SEA raises $3m from CVT; confirms exit from Omega-2 market
    • Price Sensitive: No
    • Download Document  6.02KB
    					SEA                                                                           
    27/05/2016 11:50                                                              
    GENERAL                                                                       
    PRICE SENSITIVE                                                               
    REL: 1150 HRS SeaDragon Limited                                               
                                                                                  
    GENERAL: SEA: SEA raises $3m from CVT; confirms exit from Omega-2 market      
                                                                                  
    NZX / MEDIA RELEASE   27 May 2016                                             
                                                                                  
    SeaDragon raises $3.0 m from Comvita; confirms exit from Omega-2 market       
                                                                                  
    Comvita convertible loan to provide liquidity as SeaDragon to focus on        
    significant Omega-3 opportunities.                                            
                                                                                  
    SeaDragon (NZX.SEA), New Zealand's largest refiner and blender of high        
    quality fish oils and fractions, announces its cornerstone investor Comvita   
    has agreed to advance $3 million via a convertible loan to assist the company 
    through its staged exit of a currently difficult Omega-2 market and gradual   
    build-up of the Omega-3 business.                                             
                                                                                  
    SeaDragon Chairman Colin Groves said: "Over the last 12 months SeaDragon has  
    transformed its business. With the completion of our new Omega-3 refinery, we 
    have lifted the company's processing capacity from just over 200 tonnes to    
    5,000 tonnes per year.                                                        
                                                                                  
    "We now have the production capability in Omega-3 to look to firm up both     
    supplier and customer agreements to deliver on our strategic objectives.  The 
    new refinery is performing well, we are steadily building Omega-3 raw         
    material supply relationships and we are encouraged by the response we have   
    received from potential customers.                                            
                                                                                  
    "As we signalled in late April, volatility in Omega-2 markets has             
    overshadowed these achievements, with SeaDragon experiencing an extension in  
    the Omega-2 sales cycle, and a build-up in inventory. This has resulted in a  
    slower transition from that market and a run-down of cash reserves.           
                                                                                  
     "Comvita's agreement to advance $3 million via a convertible loan allows     
    this transition from Omega-2 to Omega-3 to occur in a smoother way.           
    "SeaDragon's Board is delighted with today's agreement, it represents an      
    extension of last-year's strategic partnership, which saw Comvita subscribe   
    for $3 million of new shares and agree to partner with SeaDragon to add value 
    to the New Zealand fishing and aquaculture industries. Comvita's continuing   
    support is very valuable" Mr Groves concluded.                                
                                                                                  
    Comvita CEO Scott Coulter said: "Omega-3 fish oils are a core ingredient      
    platform for Comvita. We are committed to an on-going investment to establish 
    a unique New Zealand sourced range of high quality fish oils and are happy to 
    continue to partner SeaDragon to realise this opportunity"                    
                                                                                  
    The convertible loan will be subject to SeaDragon shareholder approval at the 
    annual meeting scheduled for in August 2016. SeaDragon will update the market 
    as soon as a date for this meeting has been set and additional information    
    will be provided to shareholders in advance of that meeting.                  
    SeaDragon expects to release its preliminary unaudited results for the year   
    to 31st March 2016 on 30th May 2016.                                          
                                                                                  
    For further information:                                                      
                                                                                  
    Investor    Medi                                                          
    Colin Groves     Richard Inder                                                
    Chairman  The Project                                                         
    Tel: +64 21 928 003   +64 21 645 643                                          
                                                                                  
    About SeaDragon www.seadragon.co.nz                                           
    SeaDragon (NZX:SEA) is New Zealand's largest refiner and blender of           
    high-quality, internationally-certified concentrated fish oils and fractions, 
    including Omega-3 oils. Our oils are sourced from fish caught in the clean    
    and pure waters around New Zealand, in the Southern Ocean, and elsewhere. We  
    have more than 20 years' experience processing fish oils and we are           
    recognised for the quality and purity of our products. We supply health       
    supplement manufacturers around the world to meet the burgeoning demand for   
    pure, high-quality fish oils, which are scientifically proven to deliver      
    significant human health benefits such as lowering the risk of heart disease, 
    improving brain function and joint health. The majority of our supply is      
    exported.                                                                     
    End CA:00283109 For:SEA    Type:GENERAL    Time:2016-05-27 11:50:27           				
 
watchlist Created with Sketch. Add SEA (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.